Cargando…
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease
BACKGROUND AND AIMS: The serum free light chain assay (sFLC) is well established for aiding in the diagnosis, prognosis, and monitoring of plasma cell proliferative disorders. There are currently two commercially available sFLC immunoassays, Freelite, based on polyclonal antibody technology, and N L...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482328/ https://www.ncbi.nlm.nih.gov/pubmed/31049418 http://dx.doi.org/10.1002/hsr2.113 |